An Overview On: Sublingual Route for Systemic Drug Delivery

Total Page:16

File Type:pdf, Size:1020Kb

An Overview On: Sublingual Route for Systemic Drug Delivery International Journal of Research in Pharmaceutical and Biomedical Sciences ISSN: 2229-3701 __________________________________________Review Article An Overview on: Sublingual Route for Systemic Drug Delivery K. Patel Nibha1 and SS. Pancholi2* 1Department of Pharmaceutics, BITS Institute of Pharmacy, Gujarat Technological university, Varnama, Vadodara, Gujarat, India 2BITS Institute of Pharmacy, Gujarat Technological University, Varnama, Vadodara, Gujarat, India. __________________________________________________________________________________ ABSTRACT Oral mucosal drug delivery is an alternative and promising method of systemic drug delivery which offers several advantages. Sublingual literally meaning is ''under the tongue'', administrating substance via mouth in such a way that the substance is rapidly absorbed via blood vessels under tongue. Sublingual route offers advantages such as bypasses hepatic first pass metabolic process which gives better bioavailability, rapid onset of action, patient compliance , self-medicated. Dysphagia (difficulty in swallowing) is common among in all ages of people and more in pediatric, geriatric, psychiatric patients. In terms of permeability, sublingual area of oral cavity is more permeable than buccal area which is in turn is more permeable than palatal area. Different techniques are used to formulate the sublingual dosage forms. Sublingual drug administration is applied in field of cardiovascular drugs, steroids, enzymes and some barbiturates. This review highlights advantages, disadvantages, different sublingual formulation such as tablets and films, evaluation. Key Words: Sublingual delivery, techniques, improved bioavailability, evaluation. INTRODUCTION and direct access to systemic circulation, the oral Drugs have been applied to the mucosa for topical mucosal route is suitable for drugs, which are application for many years. However, recently susceptible to acid hydrolysis in the stomach or there has been interest in exploiting the oral cavity which are extensively metabolized in the liver. The as a portal for delivering drugs to the systemic continuous secretion of saliva results in rapid circulation. Notwithstanding the relatively poor removal of released drug and this may desire that permeability characteristics of the epithelium, a the oral cavity be restricted to the delivery of drugs, number are offered by this route of administration. which have a short systemic circulation. The mucin Foremost among these are the avoidance of first- film, which exists on the surface of the oral mucosa pass metabolism, ease of access to the delivery site, may provide an opportunity to retain a drug and the opportunity of sustained drug delivery delivery system in contact with the mucosa for predominantly via the buccal tissues prolonged periods if it is designed to be Oral mucosal drug delivery is an alternative mucoadhesive. Such system ensures a close contact method of systemic drug delivery that offers with absorbing membrane, thus optimizing the drug several advantages over both injectable and enteral concentration gradient across the biological methods. Because the oral mucosa is highly membrane and reducing the differential pathway. vascularised, drugs that are absorbed through the The oral mucosa may be potential site for oral mucosa directly enter the systemic circulation, controlled or sustained drug delivery. Oral route is by passing the gastrointestinal tract and first-pass most preferred route by medical practitioners and metabolism in the liver. For some drugs, this manufacturer due to highest acceptability of results in rapid onset of action via a more patients. About 60% of all dosage forms available comfortable and convenient delivery route than the are the oral solid dosage form. The lower intravenous route. Not all drugs, however, can be bioavailability, long onset time and dysphagia administered through the oral mucosa because of patients turned the manufacturer to the parenterals the characteristics of the oral mucosa and the and liquid orals. But the liquid orals (syrup, physicochemical properties of the drug1. suspension, emulsion etc) have the problem of The oral route of administration is considered as accurate dosing mainly and parenterals are painful the most widely accepted route. The unique drug delivery, so most patient incompliance2. environment of the oral cavity offers its potential as The target sites for local drug delivery in the oral a site for drug delivery. Because rich blood supply cavity include the following: Buccal, Sublingual, Vol. 3 (2) Apr – Jun2012 www.ijrpbsonline.com 913 International Journal of Research in Pharmaceutical and Biomedical Sciences ISSN: 2229-3701 Periodontal region, Tongue, Gum. Other desirable also affected by the physicochemical properties of targeting sites adjacent to oral cavity include the drug to be delivered7. pharynx, larynx, adenoids and tonsils. Within the Sublingual products have been developed for oral cavity, delivery of drugs via the membranes of numerous indications ranging from migraines (for the oral cavity is classified into three categories: which rapid onset of action is important) to mental i) Sublingual delivery illness (for which patient compliance is important which is systemic delivery of drugs through the for treating chronic indications such as depression mucosal membranes lining the floor of the mouth and schizophrenia.)8 to the systemic circulation; ii) Buccal delivery Advantages which is drug administration through the mucosal • Ease of administration to patients who refuse membranes lining the cheeks and the area between to swallow a tablet, such as pediatric, geriatric the gums and upper and lower lips to the systemic patients and psychiatric patients. circulation. • Convenience in administration of drug and iii) Local delivery accurate dosing as compared to liquid formulations. which is drug delivery to periodontal, gingival, • Water is not required for swallowing the delivery for the local treatment of ulcers, bacterial dosage form, which is convenient feature for and fungal infections and periodontal disease. patients who are traveling and do not have Sublingual administration of the drug means immediate access to water. placement of the drug under the tongue and drug • Good mouth feels property helps to change the reaches directly into the blood stream through basic view of medication as "bitter pill", ventral surface of the tongue and floor of the particularly for pediatric patients. mouth. The drug solutes are rapidly absorbed into • Fast dissolution of medicament and absorption the reticulated vein which lies underneath the oral which will leads to rapid, onset of action. mucosa, and transported through the facial veins, • Some drugs are absorbed from the mouth internal jugular vein, and braciocephalic vein and pharynx and esophagus as the saliva passes down then drained in to systemic circulation.3 into the stomach, in such cases bioavailability of The sublingual route usually produces a faster drugs is increased. onset of action than orally ingested tablets and the • It provides advantages of liquid formulations portion absorbed through the sublingual blood in the form of solid dosage form. vessels bypasses the hepatic first-pass metabolic • Pregastric absorption can result in improved processes4-6 . The main mechanism for the bioavailability and as a result of reduced dosage, absorption of the drug in to oral mucosa is via improved clinical performance through a reduction passive diffusion into the lipoidal membrane. of unwanted effects. The absorption of the drug through the sublingual route is 3 to 10 times greater than oral route and is Disadvantage only surpassed by hypodermic injection. For these Since sublingual administration of drugs formulations, the small volume of saliva is usually interferes with eating, drinking, and talking, this sufficient to result in tablet disintegration in the route is generally considered unsuitable for oral cavity. Sublingual absorption is mostly rapid prolonged administration. in action, but also short acting in duration. Although this site is not well suited to Nitroglycerine, for example, is an effective sustained‐delivery systems. antianginal drug but is extensively metabolized Sublingual medication cannot be used when taken orally (>90%). It is rapidly absorbed when a patient is uncooperative or unconscious. through the sublingual mucosa, and its peak plasma The patient should not smoke while taking level is reached within 1‐2 min. Because of its sublingual medication, because smoking causes short biological half life (3‐5 min.), however the vasoconstriction of the blood vessels. This will blood concentration of nitroglycerine declines decrease the absorption of the medication. rapidly to a level below the therapeutic concentration within 10‐15 min. In terms of Sublingual glands permeability, the sublingual area of the oral cavity Salivary glands which are present in the floor of the is more permeable than the buccal (cheek) area, mouth underneath the tongue. They are also known which in turn is more permeable than the palatal as sublingual glands. They produce mucin in turn (roof of the mouth) area. The differences in produces saliva. The interior area of the mouth permeability are generally based on the relative remains lubricated due to production of the saliva thickness, the blood supply, and degree of by the glands, which is necessary for chewing and keratinization of these membranes. In addition to food swallowing. The fluid
Recommended publications
  • (12) United States Patent (10) Patent No.: US 6,515,007 B2 Murad (45) Date of Patent: Feb
    USOO6515007B2 (12) United States Patent (10) Patent No.: US 6,515,007 B2 Murad (45) Date of Patent: Feb. 4, 2003 (54) METHODS FOR MANAGING SCALP OTHER PUBLICATIONS CONDITIONS WPIDS AN 1997-389337, JP 09 169638 A, Jun. 30, 1997, (76) Inventor: Howard Murad, 4265 Marina City Dr., bstract.* Penthouse 11, Marina del Rey, CA (US) MEDLINE 79172521, Orfanos et al, Hautarzt, Mar. 1979, 90292 30(3), 124–33, abstract.* * cited by examiner (*) Notice: patentSubject is to extended any disclaimer, or adjusted the term under of this 35 Primary Examiner Rebecca Cook U.S.C. 154(b) by 0 days. (74) Attorney, Agent, or Firm-Pennie & Edmonds LLP (57) ABSTRACT (21) Appl. No.: 09/920,729 ThisS applicationCO relatesCLCSO to a ph CCUCtical compositionCOOOSOO f (22) Filed: Aug. 3, 2001 the prevention, treatment, and management of Scalp O O conditions, Such as dandruff, Seborrheic dermatitis, (65) Prior Publication Data pSoriasis, folliculitis, and hair thinning including a thera US 2002/0009423 A1 Jan. 24, 2002 peutically effective amount of an acidic component of a hydroxyacid or tannic acid, or a pharmaceutically acceptable Related U.S. Application Data Salt thereof. A preferred anti-dandruff composition and - - - method of managing dandruff includes a therapeutically (62) Pisie of Epitol N: SE filed R Aug. 5. effective amount of the acid component, a vitamin A application, now Nolog23,484Pat. No. O.Z f 1,240,filedonii. which 27, is 1998,a division now Pat o OPO and an anti-growthi- agent. A preferred anti-hairi-hai No. 6,207,694. thinning composition and method of managing thinning hair 7 includes a therapeutically effective amount of the acidic (51) Int.
    [Show full text]
  • Study Protocol and Statistical Analysis Plan
    The University of Texas Southwestern Medical Center at Dallas Institutional Review Board PROJECT SUMMARY Study Title: Ultrasound-guided fascia iliaca compartment block versus periarticular infiltration for pain management after total hip arthroplasty: a randomized controlled trial Principal Investigator: Irina Gasanova, MD Sponsor/Funding Source: Department of Anesthesiology and Pain Management, UT Southwestern Medical School IRB Number: STU 122015-022 NCT Number: NCT02658240 Date of Document: 01 April 2016 Page 1 of 7 Purpose: In this randomized, controlled, observer-blinded study we plan to evaluate ultrasound-guided fascia iliaca compartment block with ropivacaine and periarticular infiltration with ropivacaine for postoperative pain management after total hip arthroplasty (THA). Background: Despite substantial advances in our understanding of the pathophysiology of pain and availability of newer analgesic techniques, postoperative pain is not always effectively treated (1). Optimal pain management technique balances pain relief with concerns about safety and adverse effects associated with analgesic techniques. Currently, postoperative pain is commonly treated with systemic opioids, which are associated with numerous adverse effects including nausea and vomiting, dizziness, drowsiness, pruritus, urinary retention, and respiratory depression (2). Use of regional and local anesthesia has been shown to reduce opioid requirements and opioid-related side effects. Therefore, their use has been emphasized (3, 4, 5, 6). Fascia Iliaca compartment block (FICB) is a field block that blocks the nerves from the lumbar plexus supplying the thigh (i.e., lateral femoral cutaneous femoral and obturator nerves). The obturator nerve is sometimes involved in the FICB but probably plays little role in postoperative pain relief for most surgeries of the hip and proximal femur.
    [Show full text]
  • Intravenous Therapy Procedure Manual
    INTRAVENOUS THERAPY PROCEDURE MANUAL - 1 - LETTER OF ACCEPTANCE __________________________________________ hereby approves (Facility) the attached Reference Manual as of _____________________. (Date) The Intravenous Therapy Procedure Manual will be reviewed at least annually or more often when deemed appropriate. Revisions will be reviewed as they occur. Current copies of the Intravenous Therapy Procedure Manual shall be maintained at each appropriate nursing station. I have reviewed this manual and agree to its approval. __________________________ (Administrator) __________________________ (Director of Nursing) __________________________ (Medical Director) - 2 - TABLE OF CONTENTS TABLE OF CONTENTS INTRODUCTION A. Purpose 1 B. Local Standard of Practice 1 RESPONSIBILITIES A. Responsibilities: M Chest Pharmacy 1 B. Responsibilities: Administrator 1 C. Responsibilities: Director of Nursing Services (DON/DNS) 1 D. Skills Validation 2 AMENDMENTS GUIDELINES A. Resident Candidacy for IV Therapy 1 B. Excluded IV Medications and Therapies 1 C. Processing the IV Order 1 D. IV Solutions/Medications: Storage 2 E. IV Solutions/Medications: Handling 3 F. IV Solutions and Supplies: Destroying and Returning 4 G. IV Tubing 5 H. Peripheral IV Catheters and Needles 6 I. Central Venous Devices 7 J. Documentation and Monitoring 8 K. IV Medication Administration Times 9 L. Emergency IV Supplies 10 I TABLE OF CONTENTS PROTOCOLS A. IV Antibiotic 1 1. Purpose 2. Guidelines 3. Nursing Responsibilities B. IV Push 2 1. Purpose 2. Guidelines C. Anaphylaxis Allergic Reaction 4 1. Purpose 2. Guidelines 3. Nursing Responsibilities and Interventions 4. Signs and Symptoms of Anaphylaxis 5. Drugs Used to Treat Anaphylaxis 6. Physician Protocol PRACTICE GUIDELINES A. Purpose 1 B. Personnel 1 C. Competencies 1 D.
    [Show full text]
  • Mucoadhesive Buccal Drug Delivery System: a Review
    REVIEW ARTICLE Am. J. PharmTech Res. 2020; 10(02) ISSN: 2249-3387 Journal home page: http://www.ajptr.com/ Mucoadhesive Buccal Drug Delivery System: A Review Ashish B. Budhrani* , Ajay K. Shadija Datta Meghe College of Pharmacy, Salod (Hirapur), Wardha – 442001, Maharashtra, India. ABSTRACT Current innovation in pharmaceuticals determine the merits of mucoadhesive drug delivery system is particularly relevant than oral control release, for getting local systematic drugs distribution in GIT for a prolong period of time at a predetermined rate. The demerits relative with the oral drug delivery system is the extensive presystemic metabolism, degrade in acidic medium as a result insufficient absorption of the drugs. However parental drug delivery system may beat the downside related with oral drug delivery system but parental drug delivery system has significant expense, least patient compliance and supervision is required. By the buccal drug delivery system the medication are directly pass via into systemic circulation, easy administration without pain, brief enzymatic activity, less hepatic metabolism and excessive bioavailability. This review article is an outline of buccal dosage form, mechanism of mucoadhesion, in-vitro and in-vivo mucoadhesion testing technique. Keywords: Buccal drug delivery system, Mucoadhesive drug delivery system, Mucoadhesion, mucoadhesive polymers, Permeation enhancers, Bioadhesive polymers. *Corresponding Author Email: [email protected] Received 10 February 2020, Accepted 29 February 2020 Please cite this article as: Budhrani AB et al., Mucoadhesive Buccal Drug Delivery System: A Review . American Journal of PharmTech Research 2020. Budhrani et. al., Am. J. PharmTech Res. 2020; 10(02) ISSN: 2249-3387 INTRODUCTION Amongst the numerous routes of drug delivery system, oral drug delivery system is possibly the maximum preferred to the patient.
    [Show full text]
  • An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: a Review
    Muthadi Radhika Reddy /J. Pharm. Sci. & Res. Vol. 12(7), 2020, 925-940 An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: A Review Muthadi Radhika Reddy1* 1School of pharmacy, Gurunanak Institute of Technical Campus, Hyderabad, Telangana, India and Department of Pharmacy, Gandhi Institute of Technology and Management University, Vizag, Andhra Pradesh, India INTRODUCTION 2. Useful in situations where rapid onset of action Fast dissolving drug delivery systems were first developed required such as in motion sickness, allergic attack, in the late 1970s as an alternative to conventional dosage coughing or asthma forms. These systems consist of solid dosage forms that 3. Has wide range of applications in pharmaceuticals, Rx disintegrate and dissolve quickly in the oral cavity without Prescriptions and OTC medications for treating pain, the need of water [1]. Fast dissolving drug delivery cough/cold, gastro-esophageal reflux disease,erectile systems include orally disintegrating tablets (ODTs) and dysfunction, sleep disorders, dietary supplements, etc oral thin films (OTFs). The Centre for Drug Evaluation [4] and Research (CDER) defines ODTs as,“a solid dosage 4. No water is required for the administration and hence form containing medicinal substances which disintegrates suitable during travelling rapidly, usually within a matter of seconds, when placed 5. Some drugs are absorbed from the mouth, pharynx upon the tongue” [2]. USFDA defines OTFs as, “a thin, and esophagus as the saliva passes down into the flexible, non-friable polymeric film strip containing one or stomach, enhancing bioavailability of drugs more dispersed active pharmaceutical ingredients which is 6. May offer improved bioavailability for poorly water intended to be placed on the tongue for rapid soluble drugs by offering large surface area as it disintegration or dissolution in the saliva prior to disintegrates and dissolves rapidly swallowing for delivery into the gastrointestinal tract” [3].
    [Show full text]
  • Vaccine Administration Joellen Wolicki, BSN, RN and Elaine Miller, RN, BSN, MPH
    Vaccine Administration JoEllen Wolicki, BSN, RN and Elaine Miller, RN, BSN, MPH This chapter summarizes best practices related to vaccine administration, a key factor in ensuring vaccination is as safe NOTES and effective as possible. Administration involves a series of actions: assessing patient vaccination status and determining needed vaccines, screening for contraindications and precautions, educating patients, preparing and administering vaccines properly, and documenting the vaccines administered. Professional standards for medication administration, manufacturer instructions, and organizational policies and procedures should always be followed when applicable. 6 Staff Training and Education Policies should be in place to validate health care professionals’ knowledge of, and skills in, vaccine administration. All health care professionals should receive comprehensive, competency- based training before administering vaccines. Training, including an observation component, should be integrated into health care professionals’ education programs including orientation for new staff and annual continuing education requirements for all staff. In addition, health care professionals should receive educational updates as needed, such as when vaccine administration recommendations are updated or when new vaccines are added to the facility’s inventory. Training should also be offered to temporary staff who may be filling in on days when the facility is short-staffed or helping during peak periods of vaccine administration such as influenza season. Once initial training has been completed, accountability checks should be in place to ensure staff follow all vaccine administration policies and procedures. Before Administering Vaccine Health care professionals should be knowledgeable about appropriate techniques to prepare and care for patients when administering vaccines. Assess for Needed Vaccines The patient’s immunization status should be reviewed at every health care visit.
    [Show full text]
  • Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
    pharmaceutics Review Liposome-Based Drug Delivery Systems in Cancer Immunotherapy Zili Gu 1 , Candido G. Da Silva 1 , Koen van der Maaden 2,3, Ferry Ossendorp 2 and Luis J. Cruz 1,* 1 Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands 2 Tumor Immunology Group, Department of Immunology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands 3 TECOdevelopment GmbH, 53359 Rheinbach, Germany Received: 1 October 2020; Accepted: 2 November 2020; Published: 4 November 2020 Abstract: Cancer immunotherapy has shown remarkable progress in recent years. Nanocarriers, such as liposomes, have favorable advantages with the potential to further improve cancer immunotherapy and even stronger immune responses by improving cell type-specific delivery and enhancing drug efficacy. Liposomes can offer solutions to common problems faced by several cancer immunotherapies, including the following: (1) Vaccination: Liposomes can improve the delivery of antigens and other stimulatory molecules to antigen-presenting cells or T cells; (2) Tumor normalization: Liposomes can deliver drugs selectively to the tumor microenvironment to overcome the immune-suppressive state; (3) Rewiring of tumor signaling: Liposomes can be used for the delivery of specific drugs to specific cell types to correct or modulate pathways to facilitate better anti-tumor immune responses; (4) Combinational therapy: Liposomes are ideal vehicles for the simultaneous delivery of drugs to be combined with other therapies, including chemotherapy, radiotherapy, and phototherapy. In this review, different liposomal systems specifically developed for immunomodulation in cancer are summarized and discussed. Keywords: liposome; drug delivery; cancer immunotherapy; immunomodulation 1. The Potential of Immunotherapy for the Treatment of Cancer Cancer immunotherapy has been widely explored because of its durable and robust effects [1].
    [Show full text]
  • Intra-Luminal Focused Ultrasound for Augmentation of Gastrointestinal Drug Delivery
    Editorial Page 1 of 2 Intra-luminal focused ultrasound for augmentation of gastrointestinal drug delivery Ezekiel Maloney1, Joo Ha Hwang2 1Department of Radiology, 2Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, WA, USA Correspondence to: Joo Ha Hwang, MD, PhD. Division of Gastroenterology, Department of Medicine, University of Washington, Box 359773, 325 Ninth Avenue, Seattle, WA 98104, USA. Email: [email protected]. Provenance: This is a Guest Editorial commissioned by Section Editor Hui Kong, MD, PhD (Department of Respiratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China). Comment on: Schoellhammer CM, Schroeder A, Maa R, et al. Ultrasound-mediated gastrointestinal drug delivery. Sci Transl Med 2015;7:310ra168. Submitted Feb 01, 2017. Accepted for publication Feb 06, 2017. doi: 10.21037/atm.2017.03.42 View this article at: http://dx.doi.org/10.21037/atm.2017.03.42 The recent article by Schoellhammer et al., “Ultrasound- intensity ultrasound frequencies followed by quantification mediated gastrointestinal drug delivery” primarily of delivery of permeants (e.g., glucose, dextran, insulin). addresses practical limitations in drug delivery for medical Treated tissues showed enhanced transport. Similar management of inflammatory bowel disease (IBD), and findings were demonstrated in small and large bowel tissue presents pre-clinical data demonstrating that intra- for radiolabeled mesalamine and hydrocortisone. With 1 luminal, sub-ablative focused ultrasound (FUS), delivered minute of ultrasound treatment time, 3–5-fold improved via a trans-rectal transducer, can overcome some of these drug delivery was observed versus control. Additional limitations (1). The clinical application and benefit of such a ex vivo experiments utilizing variable FUS protocols to device is clear.
    [Show full text]
  • Chapter 1 Controlling Drug Delivery
    chapter 1 Controlling drug delivery Overview In this chapter we will: & differentiate drug delivery systems according to their physical state & differentiate drug delivery systems according to their route of administration & differentiate drug delivery systems according to their type of drug release & discuss drug transport across epithelial barriers. Introduction KeyPoints & Continued developments in Pharmacotherapy can be defined as the treatment chemistry, molecular biology and prevention of illness and disease by means of and genomics support the drugs of chemical or biological origin. It ranks discovery and developments among the most important methods of medical of new drugs and new drug treatment, together with surgery, physical targets. & treatment, radiation and psychotherapy. There The drug delivery system are many success stories concerning the use of employed can control the pharmacological action of a drugs and vaccines in the treatment, prevention drug, influencing its and in some cases even eradication of diseases pharmacokinetic and (e.g. smallpox, which is currently the only subsequent therapeutic human infectious disease completely profile. eradicated). Although it is almost impossible to estimate the exact extent of the impact of pharmacotherapy on human health, there can be no doubt that pharmacotherapy, together with improved sanitation, better diet and better housing, has improved people’s health, life expectancy and quality of life. Tip Unprecedented developments in genomics Combinatorial chemistry is a way to and molecular biology today offer a plethora of build a variety of structurally related new drug targets. The use of modern chemical drug compounds rapidly and synthetic methods (such as combinatorial systematically. These are assembled chemistry) enables the syntheses of a large from a range of molecular entities number of new drug candidates in shorter times which are put together in different ‘ ’ than ever before.
    [Show full text]
  • Delivery of Orally Administered Digestible Antibodies Using Nanoparticles
    International Journal of Molecular Sciences Review Delivery of Orally Administered Digestible Antibodies Using Nanoparticles Toshihiko Tashima Tashima Laboratories of Arts and Sciences, 1239-5 Toriyama-cho, Kohoku-ku, Yokohama, Kanagawa 222-0035, Japan; [email protected] Abstract: Oral administration of medications is highly preferred in healthcare owing to its simplicity and convenience; however, problems of drug membrane permeability can arise with any administra- tion method in drug discovery and development. In particular, commonly used monoclonal antibody (mAb) drugs are directly injected through intravenous or subcutaneous routes across physical barri- ers such as the cell membrane, including the epithelium and endothelium. However, intravenous administration has disadvantages such as pain, discomfort, and stress. Oral administration is an ideal route for mAbs. Nonetheless, proteolysis and denaturation, in addition to membrane impermeability, pose serious challenges in delivering peroral mAbs to the systemic circulation, biologically, through enzymatic and acidic blocks and, physically, through the small intestinal epithelium barrier. A num- ber of clinical trials have been performed using oral mAbs for the local treatment of gastrointestinal diseases, some of which have adopted capsules or tablets as formulations. Surprisingly, no oral mAbs have been approved clinically. An enteric nanodelivery system can protect cargos from proteolysis and denaturation. Moreover, mAb cargos released in the small intestine may be delivered to the systemic circulation across the intestinal epithelium through receptor-mediated transcytosis. Oral Abs in milk are transported by neonatal Fc receptors to the systemic circulation in neonates. Thus, well-designed approaches can establish oral mAb delivery. In this review, I will introduce the imple- mentation and possibility of delivering orally administered mAbs with or without nanoparticles not Citation: Tashima, T.
    [Show full text]
  • Soft Gelatin Capsules)
    ERGOCALCIFEROL- ergocalciferol capsule Blenheim Pharmacal, Inc. ---------- VITAMIN D, ERGOCALCIFEROL Capsules, USP, 1.25 mg SOFTGEL CAPSULES (Soft Gelatin Capsules) (50,000 USP Units) Rx Only DESCRIPTION Ergocalciferol Capsules, USP is a synthetic calcium regulator for oral administration. Ergocalciferol is a white, colorless crystal, insoluble in water, soluble in organic solvents, and slightly soluble in vegetable oils. It is affected by air and by light. Ergosterol or provitamin D 2 is found in plants and yeast and has no antirachitic activity. There are more than 10 substances belonging to a group of steroid compounds, classified as having vitamin D or antirachitic activity. One USP Unit of vitamin D 2 is equivalent to one International Unit (IU), and 1 mcg of vitamin D 2 is equal to 40 IU. Each softgel capsule, for oral administration, contains Ergocalciferol, USP 1.25 mg (equivalent to 50,000 USP units of Vitamin D), in an edible vegetable oil. Ergocalciferol, also called vitamin D 2 ,is 9, 10-secoergosta-5, 7,10(19),22-tetraen-3-ol,(3β,5 Z,7 E,22 E)-; (C 28H 44O) with a molecular weight of 396.65, and has the following structural formula: Inactive Ingredients: D&C Yellow #10, FD&C Blue #1, Gelatin, Glycerin, Purified Water, Refined Soybean Oil. CLINICAL PHARMACOLOGY The in vivo synthesis of the major biologically active metabolites of vitamin D occurs in two steps. The first hydroxylation of ergocalciferol takes place in the liver (to 25-hydroxyvitamin D) and the second in the kidneys (to 1,25-dihydroxy- vitamin D). Vitamin D metabolites promote the active absorption of calcium and phosphorus by the small intestine, thus elevating serum calcium and phosphate levels sufficiently to permit bone mineralization.
    [Show full text]
  • Drug Administration
    Chapter 3: Drug Administration 2 Contact Hours By: Katie Ingersoll, RPh, PharmD Author Disclosure: Katie Ingersoll and Elite do not have any actual or Questions regarding statements of credit and other customer service potential conflicts of interest in relation to this lesson. issues should be directed to 1-888-666-9053. This lesson is $12.00. Universal Activity Number (UAN): 0761-9999-17-079-H01-P Educational Review Systems is accredited by the Activity Type: Knowledge-based Accreditation Council of Pharmacy Education (ACPE) Initial Release Date: April 1, 2017 as a provider of continuing pharmaceutical education. Expiration Date: April 1, 2019 This program is approved for 2 hours (0.2 CEUs) of Target Audience: Pharmacists in a community-based setting. continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 To Obtain Credit: A minimum test score of 70 percent is needed weeks to participants who have successfully completed the post-test. to obtain a credit. Please submit your answers either by mail, fax, or Participants must participate in the entire presentation and complete online at Pharmacy.EliteCME.com. the course evaluation to receive continuing pharmacy education credit. Learning objectives After completion of this course, healthcare professionals will be able Discuss the administration of medications in patients using enteral to: and parenteral nutrition. Describe the eight rights of medication administration. Discuss special considerations for administering medications in Explain the administration of enteral and parenteral medications. pediatric and geriatric patients. Introduction Medication errors that occur at the point of drug administration poised to reduce the frequency of medication administration errors.
    [Show full text]